We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+12.8%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$237M
AUM Growth
-$4.18M
Cap. Flow
-$18.3M
Cap. Flow %
-7.71%
Top 10 Hldgs %
7.93%
Holding
416
New
61
Increased
247
Reduced
47
Closed
61

Top Buys

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$1.78M
2
EOG icon
EOG Resources
EOG
+$1.78M
3
COP icon
ConocoPhillips
COP
+$1.72M
4
IMO icon
Imperial Oil
IMO
+$1.64M
5
VNO icon
Vornado Realty Trust
VNO
+$1.59M

Top Sells

Rank Stock Value
1
RHP icon
Ryman Hospitality Properties
RHP
+$2.57M
2
WES icon
Western Midstream Partners
WES
+$2.52M
3
INN
Summit Hotel Properties
INN
+$2.43M
4
BEPC icon
Brookfield Renewable
BEPC
+$2.38M
5
PAC icon
Grupo Aeroportuario del Pacifico
PAC
+$2.16M

Sector Composition

Rank Sector Weight
1 Healthcare 30.46%
2 Real Estate 18.03%
3 Energy 13.68%
4 Materials 11.34%
5 Utilities 10.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KURA icon
326
Kura Oncology
KURA
$793M
$205K 0.09%
7,268
+132
+2% +$4.18K
TCDA
327
DELISTED
Tricida, Inc. Common Stock
TCDA
$204K 0.09%
38,593
+674
+2% +$4.23K
BLUE
328
DELISTED
bluebird bio
BLUE
$203K 0.09%
520
+9
+2% +$4.43K
CGEN icon
329
Compugen
CGEN
$212M
$200K 0.08%
23,236
+402
+2% +$4.46K
RNAM
330
DELISTED
Avidity Biosciences
RNAM
$199K 0.08%
9,138
+166
+2% +$4.06K
SYRS
331
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$193K 0.08%
2,577
+45
+2% +$4.67K
MRSN
332
DELISTED
Mersana Therapeutics
MRSN
$190K 0.08%
471
+9
+2% +$4.37K
IOVA icon
333
Iovance Biotherapeutics
IOVA
$2.04B
$189K 0.08%
5,971
+101
+2% +$4.19K
ATRA icon
334
Atara Biotherapeutics
ATRA
$72.6M
$184K 0.08%
511
+8
+2% +$3.54K
ZYME icon
335
Zymeworks
ZYME
$1.62B
$184K 0.08%
5,838
+112
+2% +$4.55K
TBIO
336
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$184K 0.08%
11,160
+201
+2% +$4.58K
WVE icon
337
Wave Life Sciences
WVE
$1.12B
$183K 0.08%
32,603
+571
+2% +$5.49K
FIV
338
DELISTED
First Trust Senior Floating Rate 2022 Target Term Fund Common Shares of Beneficial Interest
FIV
$183K 0.08%
19,412
+876
+5% +$8.1K
FMTX
339
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$176K 0.07%
6,276
+108
+2% +$3.9K
KLRS
340
Kalaris Therapeutics
KLRS
$80.9M
$175K 0.07%
325
+6
+2% +$5.04K
CCAP icon
341
Crescent Capital BDC
CCAP
$405M
$170K 0.07%
9,891
+1,825
+23% +$29.8K
PRVB
342
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$170K 0.07%
16,158
+280
+2% +$3.94K
VYGR icon
343
Voyager Therapeutics
VYGR
$181M
$168K 0.07%
35,712
+633
+2% +$4.32K
HYG icon
344
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$151K 0.06%
1,727
-2,715
-61% -$236K
CALA
345
DELISTED
Calithera Biosciences, Inc
CALA
$148K 0.06%
3,058
+54
+2% +$3.14K
INBX
346
DELISTED
Inhibrx, Inc. Common Stock
INBX
$146K 0.06%
7,268
+135
+2% +$3.94K
NKTX icon
347
Nkarta
NKTX
$152M
$142K 0.06%
4,311
+72
+2% +$3.44K
CRDF icon
348
Cardiff Oncology
CRDF
$63M
$137K 0.06%
14,785
+252
+2% +$3.06K
ARCT icon
349
Arcturus Therapeutics
ARCT
$165M
$115K 0.05%
2,785
+42
+2% +$2.5K
ATNX
350
DELISTED
Athenex, Inc. Common Stock
ATNX
$105K 0.04%
1,222
+22
+2% +$4.22K
12 13
14
15 16

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q1 2021 Portfolio in Review

As of Q1 2021, Virtus ETF Advisers held 416 positions worth $237M, down 1.7% from $241M the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Virtus ETF Advisers withdrew a net $18.3M in Q1 2021, closing 61 positions and reducing 47 holdings. Its most notable exit was Ryman Hospitality Properties, an estimated $2.57M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 30% a quarter earlier, followed by Real Estate and Energy.

Against the trend, Virtus ETF Advisers opened a new position in Pioneer Natural Resource Co. worth $1.99M.

  • Virtus ETF Advisers's largest Q1 2021 buy was Pioneer Natural Resource Co.: 12,538 shares worth $1.99M.
  • Virtus ETF Advisers added most to Oaktree Specialty Lending in Q1 2021, an estimated $216K increase.
  • Virtus ETF Advisers's biggest Q1 2021 reduction was Avient, cutting an estimated $916K.
  • Virtus ETF Advisers fully exited Ryman Hospitality Properties in Q1 2021, selling an estimated $2.57M.
  • Virtus ETF Advisers's ten largest holdings make up 7.9% of its $237M portfolio in Q1 2021.
  • Virtus ETF Advisers opened 61 new positions and closed 61 in Q1 2021.
  • Virtus ETF Advisers's portfolio value fell 1.7% quarter-over-quarter to $237M.

Based on Virtus ETF Advisers's 13F filing for Q1 2021, filed 17 May 2021.